These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4093509)

  • 1. Chemical stabilities of cefamandole nafate and metronidazole when mixed together for intravenous infusion.
    Das Gupta V; Stewart KR; Dela Torre M
    J Clin Hosp Pharm; 1985 Dec; 10(4):379-83. PubMed ID: 4093509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of cefamandole nafate and cefoxitin sodium solutions.
    Das Gupta V; Stewart KR
    Am J Hosp Pharm; 1981 Jun; 38(6):875-9. PubMed ID: 7246563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of cefamandole nafate injection with parenteral solutions and additives.
    Frable RA; Klink PR; Engel GL; Mundell EE
    Am J Hosp Pharm; 1982 Apr; 39(4):622-7. PubMed ID: 7082453
    [No Abstract]   [Full Text] [Related]  

  • 4. Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitin sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions.
    Bosso JA; Townsend RJ
    Am J Hosp Pharm; 1985 Oct; 42(10):2211-4. PubMed ID: 3864367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of frozen solutions of cefamandole nafate.
    Bornstein M; Klink PR; Farrell BT; Winely CL; Boylan JC
    Am J Hosp Pharm; 1980 Jan; 37(1):98-101. PubMed ID: 7361780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of cefamandole and cefamandole nafate in human plasma and urine by high-performance liquid chromatography with column switching.
    Lee HS; Zee OP; Kwon KI
    J Chromatogr; 1990 Jun; 528(2):425-33. PubMed ID: 2384580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability and compatibility studies of cephamandole nafate with PVC infusion bags.
    Faouzi MA; Dine T; Luyckx M; Goudaliez F; Mallevais ML; Gressier B; Brunet C; Cazin M; Cazin JC
    J Pharm Biomed Anal; 1994 Jan; 12(1):99-104. PubMed ID: 8161612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of cefonicid sodium in infusion fluids.
    Wong WW; Maderich AB; Polli GP; Ravin LJ
    Am J Hosp Pharm; 1985 Sep; 42(9):1980-3. PubMed ID: 4050816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrolysis of cefamandole nafate to cefamandole in vivo.
    Wold JS; Joost RR; Black HR; Griffith RS
    J Infect Dis; 1978 May; 137 Suppl():S17-S24. PubMed ID: 650001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical stabilities of cefuroxime sodium and metronidazole in an admixture for intravenous infusion.
    Barnes AR
    J Clin Pharm Ther; 1990 Jun; 15(3):187-96. PubMed ID: 2365756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability and pain study of cefamandole nafate.
    Foster TS; Shrewsbury RP; Coonrod JD
    J Clin Pharmacol; 1980; 20(8-9):526-33. PubMed ID: 7000857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of cefamandole nafate degradation in solid phase.
    Jelińska A; Zajac M; Gostomska J; Szczepaniak M
    Farmaco; 2003 Apr; 58(4):309-13. PubMed ID: 12727540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicologic evaluation of cefamandole nafate in laboratory animals.
    Wold JS; Welles JS; Owen NV; Gibson WR; Morton DM
    J Infect Dis; 1978 May; 137 Suppl():S51-S59. PubMed ID: 650004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical stabilities of hydrocortisone sodium succinate and several antibiotics when mixed with metronidazole injection for intravenous infusion.
    Gupta VD; Stewart KR
    J Parenter Sci Technol; 1985; 39(3):145-9. PubMed ID: 3998970
    [No Abstract]   [Full Text] [Related]  

  • 15. Impurity profile and spectrum characteristics of the isomers in cefamandole nafate using high- performance liquid chromatography/high-performance size exclusion chromatography tandem ion trap/time-of-flight mass spectrometry.
    Wang F; Gao J; Chen H; Zhu B; Li P; Wang J; Hong L
    Rapid Commun Mass Spectrom; 2022 Dec; 36(23):e9399. PubMed ID: 36114650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cefamandole nafate to cefamandole by microbiological assay.
    Winely CL; Spears JC; Scott JK
    Antimicrob Agents Chemother; 1979 Sep; 16(3):424-6. PubMed ID: 41479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrolysis of cefamandole nafate in dialysis patients.
    Nielsen RL; Wolen R; Luft FC; Ozawa T
    Antimicrob Agents Chemother; 1979 Nov; 16(5):683-5. PubMed ID: 526012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrauterine irrigation with cefamandole nafate solution at cesarean section: a preliminary report.
    Long WH; Rudd EG; Dillon MB
    Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 1):755-8. PubMed ID: 7446607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formylation of glucose by cefamandole nafate at alkaline pH.
    Indelicato JM; Stewart BA; Engel GL
    J Pharm Sci; 1980 Oct; 69(10):1183-8. PubMed ID: 7420288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delineation of the relative antibacterial activity of cefamandole and cefamandole nafate.
    Turner JR; Preston DA; Wold JS
    Antimicrob Agents Chemother; 1977 Jul; 12(1):67-72. PubMed ID: 18988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.